EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis : A Computational and Experimental Study

Mariana Sant'Anna Pereira Nicolau, Millena Almeida Resende, Cintia de Campos Chaves, Renata Santos Rodrigues, Veridiana de Melo Rodrigues, Nilson Nicolau-Junior iD, Kelly Aparecida Geraldo Yoneyama

Chemical Biology & Drug Design · 2025-09 · 106 (3)

DOI: 10.1111/cbdd.70170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 08.09.2025. Verfasst von Mariana Sant'Anna Pereira Nicolau und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil. Hauptthemen laut MEDLINE: Acyltransferases, Leishmania, Enzyme Inhibitors, Antiprotozoal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis, a disease caused by Leishmania parasites, poses a significant health threat globally, particularly in Latin America and Brazil. Leishmania amazonensis is an important species because it is associated with both cutaneous leishmaniasis and an atypical visceral form. Current treatments are hindered by toxicity, resistance, and high cost, driving the need for new therapeutic targets and drugs. N‐myristoyltransferase (NMT) is an important anti‐leishmanial target. N‐myristoyltransferase (NMT) is an important target in Leishmania parasites, as it plays a crucial role in the process of myristoylation, a lipid modification that involves the attachment of myristate, a 14‐carbon saturated fatty acid, to the N‐terminus of specific proteins. In this work, a shape‐based modeling approach was employed to identify potential NMT inhibitors in Leishmania amazonensis . Using a pyrazole sulphonamide as a reference ligand, a five‐feature shape‐based model was developed and validated. Virtual screening of the DIVERSet EXP and CL libraries (~1 million compounds) prioritized the top 500 ranked molecules per subset based on the TanimotoCombo score. Molecular docking studies identified the three highest‐ranking compounds from each subset based on ChemPLP scores and docking pose consistency. Among the selected ligands, CL 54016012, EXP 6689657, and EXP 9226834 exhibited the most favorable binding interactions, with CL 54016012 forming stable hydrogen bonds with Tyr80, Tyr217, and Tyr345. Molecular dynamics (MD) simulations indicated that ligand binding did not significantly alter NMT structural stability, although variations in binding energy and hydrogen bond were observed. CL 54016012 demonstrated the highest docking score, optimal RMSD stability, and the lowest predicted IC50 value (19.81 μM), suggesting its potential as a lead compound. In vitro cytotoxicity assays revealed that CL 54016012, CL 74995016, and EXP 6689657 reduced L. amazonensis viability in a dose‐dependent manner, placing them as promising candidates for further investigation in anti‐leishmanial drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyltransferasesLeishmaniaEnzyme InhibitorsAntiprotozoal AgentsMolecular Docking SimulationMolecular Dynamics Simulation

Stichwörter der Autor:innen

Leishmania amazonensisLeishmaniasisN‐myristoyltransferase (NMT)computer‐aided drug designdrug discoveryenzyme inhibition

Substanzen

glycylpeptide N-tetradecanoyltransferaseAcyltransferasesEnzyme InhibitorsAntiprotozoal Agents

Autor:innen und Institutionen

  • Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil.
  • Laboratory of Molecular Modeling, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil.

ORCID-Profile: Nilson Nicolau-Junior

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Sant'Anna Pereira Nicolau, M., Resende, M. A., de Campos Chaves, C., Rodrigues, R. S., de Melo Rodrigues, V., Nicolau-Junior, N., & Yoneyama, K. A. G. (2025). Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis : A Computational and Experimental Study. Chemical Biology & Drug Design, 106(3). https://doi.org/10.1111/cbdd.70170

Vancouver

Sant'Anna Pereira Nicolau M, Resende MA, de Campos Chaves C, Rodrigues RS, de Melo Rodrigues V, Nicolau-Junior N, et al. Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis : A Computational and Experimental Study. Chemical Biology & Drug Design. 2025;106(3). doi:10.1111/cbdd.70170

BibTeX
@article{SantAnnaPereiraNicolau2025,
  author = {Sant'Anna Pereira Nicolau, Mariana and Resende, Millena Almeida and de Campos Chaves, Cintia and Rodrigues, Renata Santos and de Melo Rodrigues, Veridiana and Nicolau-Junior, Nilson and Yoneyama, Kelly Aparecida Geraldo},
  title = {Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis : A Computational and Experimental Study},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {106},
  number = {3},
  doi = {10.1111/cbdd.70170}
}
Kostenlos starten →